相似文献
1
Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancer.
Rep Pract Oncol Radiother. 2011 Aug 6;16(6):243-7. doi: 10.1016/j.rpor.2011.07.001. eCollection 2011.
2
High dose rate brachytherapy in the treatment of oral cancer--the preliminary one institution experience.
Neoplasma. 2006;53(3):232-6.
3
Perioperative hyperfractionated high-dose rate brachytherapy for the treatment of soft tissue sarcomas: multicentric experience.
Ann Surg Oncol. 2010 Jan;17(1):206-10. doi: 10.1245/s10434-009-0684-1. Epub 2009 Aug 27.
4
Interstitial HDR brachytherapy (HDR-BT) in early stage mobile tongue cancers in young patients - Gliwice experience.
J Contemp Brachytherapy. 2010 Jun;2(2):61-63. doi: 10.5114/jcb.2010.14403. Epub 2010 Jul 6.
5
High dose rate brachytherapy for early stage oral tongue cancer.
Head Neck. 2002 Mar;24(3):274-81. doi: 10.1002/hed.10021.
6
Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):463-71. doi: 10.1016/j.ijrobp.2004.11.041.
7
Long-term outcome of high-dose-rate brachytherapy and perioperative brachytherapy in early mobile tongue cancer.
J Contemp Brachytherapy. 2018 Feb;10(1):64-72. doi: 10.5114/jcb.2018.74139. Epub 2018 Feb 28.
8
Brachytherapy for early oral tongue cancer: low dose rate to high dose rate.
J Radiat Res. 2003 Mar;44(1):37-40. doi: 10.1269/jrr.44.37.
9
From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications.
Brachytherapy. 2013 Nov-Dec;12(6):528-34. doi: 10.1016/j.brachy.2013.05.007. Epub 2013 Jul 11.
10
Perioperative fractionated high-dose rate brachytherapy in the treatment of soft tissue sarcomas.
Neoplasma. 2004;51(1):59-63.
引用本文的文献
1
Efficacy of adjuvant external beam radiotherapy and brachytherapy in squamous cell carcinoma of oral tongue: Long-term outcomes.
J Contemp Brachytherapy. 2024 Dec;16(6):398-409. doi: 10.5114/jcb.2024.146837. Epub 2024 Dec 31.
2
High-dose-rate interstitial brachytherapy in early stage oral tongue cancer - 15 year experience from a tertiary care institute.
J Contemp Brachytherapy. 2016 Feb;8(1):56-65. doi: 10.5114/jcb.2016.58082. Epub 2016 Feb 29.
3
Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature.
Radiol Oncol. 2014 Jan 22;48(1):1-10. doi: 10.2478/raon-2013-0057. eCollection 2014 Mar.
4
Role of extended histological examination in the assessment of local recurrence of tongue and floor of the mouth cancer.
Rep Pract Oncol Radiother. 2012 Jul 17;17(6):319-23. doi: 10.1016/j.rpor.2012.06.001. eCollection 2012.
5
Monte Carlo characterization of 169Yb as a high-dose-rate source for brachytherapy application by FLUKA code.
J Appl Clin Med Phys. 2013 Jul 8;14(4):4298. doi: 10.1120/jacmp.v14i4.4298.
本文引用的文献
1
Late nodal metastasis in early-stage node-negative oral cavity cancers after successful sole interstitial brachytherapy: an institutional experience of 42 cases in India.
Brachytherapy. 2010 Jul-Sep;9(3):254-9. doi: 10.1016/j.brachy.2009.11.001. Epub 2010 Mar 11.
2
Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma.
Brachytherapy. 2010 Jul-Sep;9(3):227-34. doi: 10.1016/j.brachy.2009.10.003. Epub 2010 Jan 29.
3
Prediction of lymphatic metastasis based on gene expression profile analysis after brachytherapy for early-stage oral tongue carcinoma.
Radiother Oncol. 2008 May;87(2):237-42. doi: 10.1016/j.radonc.2007.12.027. Epub 2008 Jan 25.
4
Treatment of oral cavity and oropharyngeal cancer. Indications, technical aspects, and results of interstitial brachytherapy.
Strahlenther Onkol. 2004 Nov;180(11):710-7. doi: 10.1007/s00066-004-9196-x.
5
Neck node metastasis after successful brachytherapy for early stage tongue carcinoma.
Radiother Oncol. 2003 Aug;68(2):129-35. doi: 10.1016/s0167-8140(03)00187-7.
6
Brachytherapy for early oral tongue cancer: low dose rate to high dose rate.
J Radiat Res. 2003 Mar;44(1):37-40. doi: 10.1269/jrr.44.37.
7
Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer.
Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):171-5. doi: 10.1016/s0360-3016(01)01561-9.
8
The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma.
Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1190-8. doi: 10.1016/s0360-3016(01)01567-x.
9
High-dose rate interstitial brachytherapy for stage I-II tongue cancer.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Nov;90(5):667-70. doi: 10.1067/moe.2000.110087.
10
Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):767-75. doi: 10.1016/s0360-3016(99)00068-1.
Zotero 插件